Chemed Co. (NYSE:CHE - Get Free Report) EVP Spencer S. Lee sold 732 shares of the company's stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total transaction of $421,353.84. Following the completion of the sale, the executive vice president now directly owns 18,287 shares of the company's stock, valued at $10,526,362.94. The trade was a 3.85 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.
Chemed Stock Up 0.3 %
NYSE CHE opened at $573.11 on Friday. Chemed Co. has a 52 week low of $523.33 and a 52 week high of $654.62. The company has a 50 day moving average price of $578.27 and a 200 day moving average price of $565.09. The firm has a market cap of $8.63 billion, a PE ratio of 28.96, a price-to-earnings-growth ratio of 2.42 and a beta of 0.46.
Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. During the same period in the previous year, the company posted $5.32 earnings per share. The business's revenue for the quarter was up 7.4% on a year-over-year basis. On average, equities research analysts anticipate that Chemed Co. will post 21.43 earnings per share for the current fiscal year.
Chemed Announces Dividend
"Start Earning Extra Income with Just $30"
From Darwin | Ad
What if you could unlock a steady income stream from stocks priced under $30?
Our new guide walks you through simple, effective options strategies designed for everyday investors. With step-by-step insights, you’ll learn how to transform familiar names like Ford and Intel into reliable monthly income generators.
Claim Your Free Report Now: “Options Made Simple – 2 Affordable Stocks for Monthly Income”
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Monday, November 18th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, November 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. Chemed's payout ratio is 10.11%.
Wall Street Analysts Forecast Growth
A number of analysts have weighed in on the company. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a report on Saturday. Royal Bank of Canada dropped their price objective on Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a research report on Tuesday, November 5th.
Get Our Latest Analysis on CHE
Hedge Funds Weigh In On Chemed
Several hedge funds have recently modified their holdings of CHE. Price T Rowe Associates Inc. MD boosted its stake in Chemed by 105.7% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 63,733 shares of the company's stock worth $40,913,000 after purchasing an additional 32,752 shares in the last quarter. Cetera Advisors LLC purchased a new position in shares of Chemed in the first quarter worth $267,000. DekaBank Deutsche Girozentrale lifted its stake in shares of Chemed by 34.5% during the first quarter. DekaBank Deutsche Girozentrale now owns 154,579 shares of the company's stock worth $98,516,000 after buying an additional 39,633 shares during the period. Park Place Capital Corp grew its holdings in shares of Chemed by 170.0% during the second quarter. Park Place Capital Corp now owns 1,080 shares of the company's stock valued at $586,000 after buying an additional 680 shares during the last quarter. Finally, GAMMA Investing LLC increased its position in shares of Chemed by 34.4% in the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company's stock valued at $47,000 after acquiring an additional 22 shares during the period. Institutional investors and hedge funds own 95.85% of the company's stock.
About Chemed
(
Get Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
